Modi Mansi, Garg Pinky
Department of Biochemistry, North Delhi Municipal Corporation Medical College, Delhi, India.
Clin Exp Reprod Med. 2025 Mar;52(1):71-78. doi: 10.5653/cerm.2023.06779. Epub 2024 Aug 19.
Researchers have long been captivated by the complex molecular interactions between vitamin D and the thyroid gland. Hypothyroidism affects 2% to 4% of women of reproductive age and can impact fertility through anovulatory cycles, luteal phase defects, hyperprolactinemia, and sex hormone imbalances. This study investigated the relationship between thyroid disease and the severity of vitamin D deficiency across different age groups.
A retrospective study was conducted of 286 patient samples from individuals aged 18 to 60 years who were processed in the clinical biochemistry laboratory of our hospital. Samples were tested for thyroid-stimulating hormone (TSH) and vitamin D (specifically, vitamin D3) levels. The study samples were categorized into four clinically relevant groups based on TSH levels and into three groups based on serum 25-hydroxyvitamin D (25(OH)D) levels.
Most of the samples were from female patients (n=269), and the most common age group was 18 to 35 years (n=191, 66.78%). Subclinical hypothyroidism was identified in 120 patients, while vitamin D deficiency was present in 237 (82.87%) participants. A significant association was observed between vitamin D deficiency and the presence of thyroid disorders. Additionally, a significant negative correlation was found between TSH and vitamin D levels. Polycystic ovary syndrome was noted in 103 female patients (36.01%).
TSH and 25(OH)D levels should be screened in all women of reproductive age, not just those in high-risk groups, as subclinical and occult hypothyroidism may otherwise go undiagnosed. Furthermore, TSH should be considered the primary screening test.
长期以来,研究人员一直着迷于维生素D与甲状腺之间复杂的分子相互作用。甲状腺功能减退影响2%至4%的育龄女性,可通过无排卵周期、黄体期缺陷、高催乳素血症和性激素失衡影响生育能力。本研究调查了不同年龄组甲状腺疾病与维生素D缺乏严重程度之间的关系。
对我院临床生化实验室处理的286例18至60岁患者样本进行回顾性研究。检测样本中的促甲状腺激素(TSH)和维生素D(具体为维生素D3)水平。研究样本根据TSH水平分为四个临床相关组,根据血清25-羟基维生素D(25(OH)D)水平分为三组。
大多数样本来自女性患者(n = 269),最常见的年龄组为18至35岁(n = 191,66.78%)。120例患者被诊断为亚临床甲状腺功能减退,237例(82.87%)参与者存在维生素D缺乏。观察到维生素D缺乏与甲状腺疾病之间存在显著关联。此外,发现TSH与维生素D水平之间存在显著负相关。103例女性患者(36.01%)被诊断为多囊卵巢综合征。
所有育龄女性都应筛查TSH和25(OH)D水平,而不仅仅是高危人群,否则亚临床和隐匿性甲状腺功能减退可能会漏诊。此外,应将TSH视为主要筛查试验。